Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Pre-exposure prophylaxis Stories

Anti-HIV Pill Guidelines Changed To Include Straight Men And Women
2012-08-10 14:44:27

Connie K. Ho for redOrbit.com — Your Universe Online U.S. health officials recently issued recommendations to physicians with heterosexually-active patients considering the use of Truvada, a pill that can reduce the risk of the HIV virus for people engaging in sexual intercourse. The pill was originally only advised to be given to high-risk gay and bisexual men. The news is of particular interest to straight people who make up 25% of new HIV cases every year, according to the...

2012-07-27 06:21:48

RESEARCH TRIANGLE PARK, N.C., July 27, 2012 /PRNewswire-USNewswire/ -- When the HIV Prevention Trials Network (HPTN) 052 investigators released their landmark study results last year showing that treatment can reduce HIV transmission by 96% in serodiscordant couples, questions were raised about the cost of early antiretroviral therapy (ART) and if it should be universally implemented. Data presented today at the XIX International AIDS Conference in Washington, D.C. show that treatment as...

2012-07-19 12:09:34

Safety, tolerability study to enroll MSM in the United States and Puerto Rico Scientists are launching the first clinical trial to test whether drug regimens containing maraviroc, a medication currently approved to treat HIV infection, are also safe and tolerable when taken once daily by HIV-uninfected individuals at increased risk for acquiring HIV infection. The eventual goal is to see if the drug regimens can reduce the risk of infection. The trial involves a strategy known as...

HIV Prevention Pill Truvada Approved by FDA
2012-07-17 09:18:10

Connie K. Ho for redOrbit.com — Your Universe Online The U.S. Food and Drug Administration (FDA) recently approved Truvada, which decreases the risk of HIV invention in uninfected individuals who have a high risk of contracting HIV Infection or who are engaged in sexual activities with a partner who is HIV-infected. Truvada is the first drug approved by the FDA that focuses on reducing the risk of HIV infection acquired through sexual activities. Taken daily, the drug is be used...

2012-07-16 10:25:18

SAN FRANCISCO, July 16, 2012 /PRNewswire-USNewswire/ -- The fight against HIV/AIDS reached a watershed moment today when the U.S. Food and Drug Administration (FDA) approved the first drug to prevent the spread of HIV. The drug, Truvada, is approved for use by HIV-negative individuals at high risk for infection as part of a comprehensive prevention package that includes regular condom use, HIV testing, and risk reduction and adherence counseling. The strategy is known as pre-exposure...

2012-07-16 10:25:05

NEW YORK, July 16, 2012 /PRNewswire-USNewswire/ -- AVAC today hailed the decision by the US Food and Drug Administration (FDA) to approve the antiretroviral drug emtricitabine/tenofovir disoproxil fumarate (TDF/FTC or Truvada) for use as pre-exposure prophylaxis (PrEP) among sexually active HIV-negative adult men and women. "This is a watershed moment for both US and global HIV prevention efforts," said Mitchell Warren, executive director of AVAC. "This is the first completely new...

2012-07-11 14:20:47

AVAC Lays out Priorities to Ensure Access NEW YORK, July 11, 2012 /PRNewswire-USNewswire/ -- Publication of data from three trials of pre-exposure prophylaxis (PrEP) for HIV - including the pivotal Partners PrEP trial - today in the New England Journal of Medicine provides strong evidence that HIV-negative men and women who consistently take a daily antiretroviral (ARV) pill (either TDF/FTC, brand name Truvada, or TDF, brand name Viread) can significantly reduce their risk of HIV...

2012-07-11 14:20:33

RESEARCH TRIANGLE PARK, N.C., July 11, 2012 /PRNewswire-USNewswire/ -- Results of the FHI 360 FEM-PrEP HIV-prevention trial reinforce the key role of adherence in HIV-prevention studies and the need to determine better approaches to support adherence in future pre-exposure prophylaxis (PrEP) programs. Despite targeted counseling and support, adherence to the drug regimen was low, suggesting that women in the clinical trial population may have had difficulty adhering to a daily pill regimen....

2012-05-29 05:16:22

(Ivanhoe Newswire) -- A new study shows that pre-exposure preventative treatment for suspected HIV may be effective for those in high-risk groups. "Although post-exposure prophylaxis has a long history of success, newer methods such as pre-exposure prophylaxis and earlier treatment in the course of infection ("treatment as prevention") are being implemented with some success," Dr. Isaac Bogoch, Harvard Medical School and the Division of Infectious Diseases, Massachusetts General Hospital,...

2012-05-28 19:24:01

While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups, states a review of evidence published in CMAJ (Canadian Medical Association Journal). "Although postexposure prophylaxis has a long history of success, newer methods such as pre-exposure prophylaxis and earlier treatment in the course of infection ("treatment as prevention") are being implemented with some success,"...